Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 15,000 shares at $166.39 ($2.6M) on 2015-05-22, disclosed to the SEC on 2015-05-27.
Scheduled sale ($2.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.39 | 1,600 | $266K | 10.4% |
| 2 | $168.20 | 1,450 | $244K | 9.5% |
| 3 | $169.25 | 2,000 | $339K | 13.2% |
| 4 | $170.24 | 3,794 | $646K | 25.3% |
| 5 | $171.35 | 1,653 | $283K | 11.1% |
| 6 | $172.47 | 4,003 |
| $690K |
| 27.0% |
| 7 | $173.39 | 500 | $87K | 3.4% |
| Total | $170.32 avg | 15,000 | $2.6M | 100% |
| Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-22 | $1.9M | — | Filing → |
| BLUE | SELL | 2015-04-08 | $1.8M | — | Filing → |